GCC Context — BTS/GINA Evidence-Based Clinical Reference | Paediatric Nursing Competency Guide
| Step | Treatment | Details | Notes |
|---|---|---|---|
| Step 1 | SABA PRN | Salbutamol 100mcg — 2–4 puffs via spacer + mask as needed | For intermittent symptoms only (<3×/week) |
| Step 2 | Low-dose ICS | Fluticasone 50mcg BD via spacer OR Budesonide 200mcg BD nebuliser (under 2) | DAILY even when well — education critical |
| Step 3 | Add LTRA | Montelukast 4mg (age 2–5) / 4mg granules (age 1–2) once daily at night | NOT LABA in under 5s; LTRA is add-on choice |
| Step 4 | Specialist Referral | Refer to paediatric respiratory / allergy specialist | Consider diagnosis review, adherence, technique |
| Step | Treatment | Drug / Dose | Notes |
|---|---|---|---|
| Step 1 | SABA PRN | Salbutamol 100–200mcg PRN | Review: if >3×/week — step up |
| Step 2 | Low ICS | Fluticasone 50–100mcg BD or Beclometasone 100–200mcg BD | Daily preventer — minimum effective dose |
| Step 3 | Add LABA | Salmeterol 25–50mcg BD (combined with ICS: Seretide/Advair) | NEVER salmeterol without ICS — safety risk |
| Step 3+ | SMART/MART | Budesonide/Formoterol as both preventer AND reliever (age >12) | Reduces exacerbations; single inhaler strategy |
| Step 4 | High ICS | Fluticasone up to 500mcg BD + LABA + LTRA consider | Growth monitoring essential at high ICS doses |
| Step 5 | Biologics | Omalizumab (anti-IgE, allergic asthma age >6) / Mepolizumab (anti-IL5, eosinophilic age >6) | Specialist only; approved by MOH Saudi/DHA UAE |
Child's Name: ________________________ Date of Birth: ____________ Hospital No: ____________
Preventer: ________________________ Dose: _______ Reliever: ________________________
Personal Best PEFR: ________ L/min Reviewed by: ________________________ Date: ____________
Note: Provide this plan in Arabic for GCC families — خطة العمل للربو (Asthma Action Plan)
1. A 4-year-old child in Riyadh presents with wheeze during a dust storm. SpO2 is 91%, she is using accessory muscles and can only speak in words. What is the BTS severity classification?
A. Mild asthma B. Moderate asthma C. Severe asthma D. Life-threatening asthma2. A Muslim parent asks whether their 8-year-old child should use their fluticasone preventer inhaler during Ramadan. What is the correct advice?
A. Stop the inhaler during Ramadan as it breaks the fast B. Continue the inhaler — inhaled medication does not break the fast C. Switch to oral montelukast instead during Ramadan D. Use only at Iftar and Suhoor times3. A 6-year-old child receives IV magnesium sulphate 50mg/kg over 20 minutes for life-threatening asthma. During the infusion, the nurse notes absent knee jerk reflexes. What is the priority action?
A. Continue the infusion — this is an expected finding B. Increase the infusion rate to complete it faster C. Stop the infusion immediately and administer calcium gluconate D. Check serum magnesium level and await result before acting4. A mother uses a plastic MDI spacer for her 3-year-old's salbutamol. She cleans it daily by drying it thoroughly with a towel. The child's asthma remains poorly controlled despite good technique. What is the most likely problem with spacer management?
A. She is cleaning it too frequently B. Towel drying creates electrostatic charge which reduces drug delivery C. She should use a nebuliser instead for this age group D. Daily cleaning removes the anti-drug coating5. A family from Jeddah mentions they give their child with asthma black seed (Nigella sativa) oil daily as advised by a traditional healer, in place of the prescribed fluticasone. What is the most appropriate nursing response?
A. Agree that black seed has proven asthma benefits and can replace ICS B. Dismiss the practice entirely and insist they stop immediately C. Acknowledge the cultural practice respectfully, explain ICS must not be stopped, and clarify black seed has limited paediatric evidence D. Report the family to child protection services for non-adherence